Study of antileukemic effect of CpG-oligodeoxynucleotides treated cord blood / 中华血液学杂志
Chinese Journal of Hematology
; (12): 13-16, 2004.
Article
in Zh
| WPRIM
| ID: wpr-291461
Responsible library:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the antileukemic effect of lymphocytes from cord blood treated by CpG-oligodeoxynucleotides (CpG-ODN).</p><p><b>METHODS</b>Lymphocytes from cord blood were exposed to different oligodeoxynucleotides containing a panel of CpG-ODN and were cultured with K562 cells. The cytotoxic effects were detected by MTT method. Immunological markers of cord blood treated by CpG-ODN(3) which showed highest activity were measured with flow cytometry.</p><p><b>RESULTS</b>Different CpG-motifs have different immunostimulatory activity and CpG-ODN(3) has the highest one. After treated by CpG-ODN(3), NK killing activity to K562 cells increased in a dose-dependent manner, and CD(3), CD(4), CD(19) and CD(56) increased to (60.6 +/- 7.9)%, (40.2 +/- 3.5)%, (22.4 +/- 1.9)% and (15.5 +/- 3.1)%, respectively.</p><p><b>CONCLUSION</b>CpG-ODN could reinforces the immunological competence of cord blood lymphocytes and their effects on K562 cells. This provides a new approach to reinforce the antitumor effects of cord blood.</p>
Full text:
1
Index:
WPRIM
Main subject:
Oligodeoxyribonucleotides
/
Pharmacology
/
Therapeutics
/
Blood
/
Lymphocytes
/
Leukemia
/
Antigens, CD
/
Adjuvants, Immunologic
/
K562 Cells
/
Reverse Transcriptase Polymerase Chain Reaction
Limits:
Humans
Language:
Zh
Journal:
Chinese Journal of Hematology
Year:
2004
Type:
Article